文献速递消化内镜

使用GLP-1受体激动剂患者的肠道准备质量:系统综述与荟萃分析

Bowel preparation quality in patients using glucagon-like peptide-1 agonists: a systematic review and meta-analysis.
PubMed 文献 · Gastrointest Endosc · 2025-08-20

该系统综述与荟萃分析纳入6项研究,评估GLP-1受体激动剂(GLP-1 RA)对结肠镜肠道准备质量的影响。结论认为GLP-1 RA使用不影响结肠镜肠道准备,不推荐检查前停用GLP-1 RA。

要点

  • GLP-1 RA组与对照组肠道准备不充分事件合并率无显著差异。
  • 3项研究中GLP-1 RA组BBPS平均评分显著更低,但异质性高。
  • 不推荐结肠镜检查前停用GLP-1受体激动剂。

核心结论

  • GLP-1 RA使用不影响结肠镜肠道准备,不推荐检查前停用GLP-1 RA。
  • 需更多证据确认当前发现。

研究设计与样本

  • 系统综述与荟萃分析,检索多个数据库,最终纳入6项研究。
  • 采用随机效应模型进行统计分析。

关键数值与推荐

  • 主要终点为BBPS测量的肠道准备质量和肠道准备不充分事件频率。

临床怎么用

  • 结肠镜检查前无需仅因使用GLP-1 RA而停药。

局限性

  • 纳入研究数量少(6项),BBPS评分分析异质性高(I2=91%)。
  • 需更多证据确认当前发现。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND AIMS: Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) are now the mainstay treatment for many chronic conditions, including diabetes mellitus, obesity, heart failure, and chronic kidney disease. GLP-1 RAs may affect bowel preparation for a colonoscopy by modifying intestinal motility and gastric emptying. We conducted a systematic review and meta-analysis to investigate the impact of GLP-1 RA use on bowel preparation quality, measured by the Boston Bowel Preparation Scale, and the frequency of inadequate preparation events. METHODS: Multiple databases were searched for studies investigating the impact of GLP-1 RA on bowel preparation for colonoscopy. Primary end points included bowel preparation quality, measured by the Boston Bowel Preparation Scale (BBPS), and the frequency of inadequate preparation events. Random-effects model was used for statistical analysis. RESULTS: Six studies were included in the final meta-analysis. There was no significant difference in the pooled rate of inadequate bowel preparation events between the GLP-1 RA group and the control group (odds ratio, 1.00; 95% CI, 0.73-1.37; P = .99; I2 = 33%). Mean BBPS score reported in 3 studies was significantly lower in the GLP-1 RA group (mean difference, -0.36; 95% CI, 0.44 to -0.28; P < .001; I2 = 91%). CONCLUSIONS: GLP-1 RA use does not impact bowel preparation for colonoscopy as evident by our study. We do not recommend discontinuing GLP-1 RAs before colonoscopy. More evidence is needed to confirm the current findings.

来源:Gastrointest Endosc,查看原文。版权归原作者所有。

引用

  1. Ahmed Z, Iqbal A, Arif SF, et al. Bowel preparation quality in patients using glucagon-like peptide-1 agonists: a systematic review and meta-analysis. Gastrointest Endosc. 2025. PMID: 40846241. doi:10.1016/j.gie.2025.08.027

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。